Metabolic control probability in tumour subvolumes or how to guide tumour dose redistribution in non-small cell lung cancer (NSCLC): An exploratory clinical study
Abstract Purpose To characterize the relationship between pre-radiotherapy18 Fluorodeoxyglucose (FDG) uptake in a tumour voxel, radiation dose and the probability to achieve metabolic control in the tumour voxel after radiotherapy. Materials and methods Thirty-nine patients with inoperable stage I-I...
Saved in:
Published in | Radiotherapy and oncology Vol. 91; no. 3; pp. 393 - 398 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Ireland
Elsevier Ireland Ltd
01.06.2009
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Abstract Purpose To characterize the relationship between pre-radiotherapy18 Fluorodeoxyglucose (FDG) uptake in a tumour voxel, radiation dose and the probability to achieve metabolic control in the tumour voxel after radiotherapy. Materials and methods Thirty-nine patients with inoperable stage I-III non-small cell lung cancer, treated with radiotherapy (RT) alone or sequential chemo radiation were analysed retrospectively. Twenty-two showed metabolic active areas in the tumour 3 months post-radiotherapy, which is known to be a surrogate for persistent local tumour failure and worse survival. Pre- and post-RT FDG-PET-CT scans were registered and the metabolic active zones within the tumour after RT were projected on the pre-RT scan. Multi-level logistic regression was performed to determine the relation between the FDG uptake if a voxel pre-RT and its metabolic state after RT. Results The probability that a voxel is metabolically controlled (mVCP), decreased significantly with increasing FDG uptake in a voxel (SUV) (OR = 0.72), increasing tumour volume (20 cm3 ) (OR = 0.89) and increasing dose (Gy) (OR = 0.99). Inter-patient differences in mVCP were substantial. Conclusion A methodology was presented to derive relationships between FDG uptake, dose and metabolic control. Although no strong dose effect relation was demonstrated, mVCP decreased with increasing FDG uptake and tumour volume. |
---|---|
ISSN: | 0167-8140 1879-0887 |
DOI: | 10.1016/j.radonc.2009.02.020 |